TNDM - CIK 0001438133
The table below shows TANDEM DIABETES CARE INC's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $90.63M | $69.23M | $58.87M | $172.52M | $71.18M | $94.61M |
| Short-term investments | $202.03M | $369.10M | $409.04M | $444.38M | $552.63M | $390.32M |
| Receivables | $165.49M | $114.58M | $105.56M | $114.72M | $110.72M | $82.19M |
| Inventory | $128.77M | $149.61M | $157.94M | $111.12M | $68.55M | $63.72M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $618.14M |
| $724.49M |
| $747.99M |
| $849.98M |
| $811.52M |
| $637.24M |
| Property, plant & equipment | $83.58M | $78.15M | $76.54M | $68.55M | $50.39M | $50.02M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $881.11M | $967.66M | $952.66M | $1.05B | $905.14M | $716.41M |
| Accounts payable | $47.07M | $44.73M | $49.59M | $55.73M | $28.03M | $17.80M |
| Total current liabilities | $242.72M | $247.05M | $195.26M | $165.29M | $131.86M | $103.85M |
| Long-term debt | $310.04M | $308.27M | - | - | - | - |
| Total liabilities | $725.94M | $704.56M | $639.03M | $612.84M | $472.02M | $350.11M |
| Retained earnings | -$1.25B | -$1.05B | -$951.80M | -$729.19M | -$634.60M | -$659.21M |
| Total equity | $155.17M | $263.10M | $313.63M | $439.95M | $433.11M | $366.31M |